Phase II study of pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation status

Growth Factor ◽

Combination Therapy ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Mutation Status ◽

Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status

Journal of Hematology & Oncology ◽

10.1186/s13045-015-0151-3 ◽

2015 ◽

Vol 8 (1) ◽

Cited By ~ 26

Author(s):

Wenzhao Zhong ◽

Xuening Yang ◽

Honghong Yan ◽

Xuchao Zhang ◽

Jian Su ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Phase Ii Study ◽

Neoadjuvant Treatment ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Mutation Status ◽

A phase II study of gefitinib versus vinorelbine or gemcitabine in chemotherapy-naïve elderly patients with advanced non-small cell lung cancer based on epidermal growth factor receptor mutation status.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7559 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7559-7559

Author(s):

S. Fujita ◽

N. Katakami ◽

K. Masago ◽

H. Yoshioka ◽

K. Tomii ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Mutation Status ◽

Programmed death-ligand 1 expression according to epidermal growth factor receptor mutation status in pretreated non-small cell lung cancer

Oncotarget ◽

10.18632/oncotarget.22837 ◽

2017 ◽

Vol 8 (69) ◽

pp. 113807-113816 ◽

Cited By ~ 4

Author(s):

Akito Hata ◽

Nobuyuki Katakami ◽

Shigeki Nanjo ◽

Chiyuki Okuda ◽

Reiko Kaji ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Mutation Status ◽

Programmed Death Ligand 1 ◽

Programmed Death ◽

Phase II trial of paclitaxel-carboplatin with intercalated gefitinib for untreated, epidermal growth factor receptor gene mutation status unknown non-small cell lung cancer

Thoracic Cancer ◽

10.1111/1759-7714.12074 ◽

2014 ◽

Vol 5 (2) ◽

pp. 149-154 ◽

Cited By ~ 2

Author(s):

Jianliang Yang ◽

Yuankai Shi ◽

Xiangru Zhang ◽

Jianping Xu ◽

Bin Wang ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Phase Ii Trial ◽

Receptor Gene ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Mutation Status ◽

Association of radiomic features with epidermal growth factor receptor mutation status in non-small cell lung cancer and survival treated with tyrosine kinase inhibitors

Nuclear Medicine Communications ◽

10.1097/mnm.0000000000001076 ◽

2019 ◽

Vol 40 (11) ◽

pp. 1091-1098

Author(s):

Changbin Wang ◽

Xinzhe Dong ◽

Xiaorong Sun ◽

Ran Zhang ◽

Ligang Xing

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Mutation Status ◽

Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer

Neuroradiology ◽

10.1007/s00234-020-02529-2 ◽

2020 ◽

Author(s):

Yae Won Park ◽

Chansik An ◽

JaeSeong Lee ◽

Kyunghwa Han ◽

Dongmin Choi ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Diffusion Tensor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Mutation Status ◽

Assessment of epidermal growth factor receptor (EGFR) and K-ras mutation status in cytologic stained smears of non-small cell lung cancer (NSCLC) patients.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7560 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7560-7560

Author(s):

M. D. Lozano ◽

A. Gurpide ◽

J. I. Echeveste ◽

A. Del Barrio ◽

J. L. Perez-Gracia ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Ras Mutation ◽

Mutation Status ◽

Epidermal Growth ◽

Nsclc Patients

Correlation of epidermal growth factor receptor mutation status in plasma and tissue samples of patients with non-small cell lung cancer

Journal of Cancer Research and Therapeutics ◽

10.4103/jcrt.jcrt_515_18 ◽

2020 ◽

Vol 16 (4) ◽

pp. 843

Author(s):

Choonhee Son ◽

Mee-Sook Roh ◽

Neul-Bom Yoon ◽

Seul Lee ◽

Bo-Hyoung Kang ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Tissue Samples ◽

Mutation Status ◽

Can peripheral blood be used as surrogate in detecting epidermal growth factor receptor mutation status in advanced non-small cell lung cancer patients? A meta-analysis

Oncotarget ◽

10.18632/oncotarget.20291 ◽

2017 ◽

Vol 8 (44) ◽

pp. 78057-78067 ◽

Cited By ~ 1

Author(s):

Xiaowei Mao ◽

Yujun Zhang ◽

Fangfang Xie ◽

Xiaoxuan Zheng ◽

Jiayuan Sun

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Mutation Status ◽

Lung Cancer Patients ◽

P3-128: Correlation of the epidermal growth factor receptor mutations with clinical outcomes in patients with non–small cell lung cancer treated gefitinib: an exploratory molecular analysis of a prospective phase II study

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000284103.12311.8d ◽

2007 ◽

Vol 2 (8) ◽

pp. S733-S734

Author(s):

Hyewon Lee ◽

Hoyong Sim ◽

Se Hoon Park ◽

Jinny Park ◽

Eun Kyung Cho ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Prospective Phase ◽